|

Ravulizumab Clinical Trials

3 actively recruiting trials across 1 location

Also known as: Ultomiris

Pipeline

Phase 2: 1

Top Sponsors

  • Mayo Clinic1
  • AstraZeneca1
  • Alexion Pharmaceuticals, Inc.1

Indications

  • Cancer2
  • Liver Disease1
  • Preeclampsia1
  • Myasthenia Gravis, Generalized1
  • Anti-AChR Antibody Positive1

Other2 trials

Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Rochester, Minnesota1 trial

Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

Mayo Clinic Minnesota

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.